ISRG stock down 3.59% to $478.88 on NASDAQ 04 Feb 2026: AI-led recovery watch

ISRG stock trades at $478.88 intraday on NASDAQ, down 3.59% on higher volume. Investors are watching Intuitive Surgical, Inc. after a stretch of strong revenue growth and hefty analyst price targets. Today’s pullback connects to profit-taking and recent insider sales. We use AI-driven metrics to link fundamentals, technicals, and analyst views for a clear short-term view.

ISRG stock intraday snapshot and price action

Intuitive Surgical, Inc. (ISRG) opened at $495.21 and trades between $476.79 and $499.00 today. Volume is 3,796,796 shares versus an average of 2,031,075. Market cap sits near $171.67 billion on the NASDAQ United States market. The one-day move equals a -3.59% decline from the prior close of $496.73.

Earnings, growth and valuation metrics for ISRG stock

Latest reported EPS is $7.82 and trailing P/E is 61.24. Last quarter revenue was $2.87 billion, up 18.8% year over year. Key ratios show strong margins: net margin 28.38% and ROE about 16.72%. Balance sheet cash per share is $13.83 and current ratio is 4.73, indicating liquidity strength.

AI strategy and market position in healthcare

Intuitive Surgical sells the da Vinci system and Ion platform, expanding into diagnostics. The company integrates software and services that benefit from AI-enabled analytics. This positions ISRG stock to gain from procedural volume growth and tech-led efficiency at hospitals. Analysts cite durable adoption and a wide installed base as key advantages.

Technicals, momentum and trading signals for ISRG stock

Short-term technicals show RSI 65.69, MACD histogram 0.11, and ADX 22.53, signaling continued trend interest. The 50-day average is $557.05 and the 200-day average is $516.37, both above today’s price. Bollinger middle band sits near $566.22, showing the stock trades below near-term trend resistance.

Meyka AI rates ISRG with a score out of 100 and forecast

Meyka AI rates ISRG with a score out of 100: 74.57 / 100 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly target of $504.41, a quarterly target of $508.28, and a yearly target of $605.93. At the current price of $478.88, the model implies a yearly upside of 26.54%. Forecasts are model-based projections and not guarantees.

Analyst targets, catalysts and risk factors for ISRG stock

Wall Street targets vary from $550.00 to $714.00, with a consensus target near $620.41. Positive catalysts include procedure volume growth, Ion adoption, and recurring consumables revenue. Risks include a premium valuation, ongoing insider selling, and supply chain pressures. Monitor upcoming earnings and device approval news for near-term moves.

Final Thoughts

ISRG stock trades at $478.88 after a -3.59% intraday drop that reflects profit-taking and heavier volume. Fundamentals remain strong: recent quarterly revenue growth was 18.8%, net margin 28.38%, and EPS $7.82. Analyst coverage is broadly positive, with several targets above $600.00. Meyka AI’s forecast model projects a yearly level of $605.93, implying 26.54% upside versus today’s price. For AI-stock investors, Intuitive Surgical blends robotics moat and software upside. That mix supports a Buy-grade from our model, but premium multiples and insider sales raise near-term volatility. Use position sizing and watch the next earnings date and FDA updates before adding exposure.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.